Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 8Withdrawn 2Unknown 2Recruiting 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Motor Activity 34Neoplasms 17Breast Neoplasms 15Carcinoma, Non-Small-Cell Lung 5Polycystic Ovary Syndrome 4Lymphoma 4Sarcopenia 3Prostatic Neoplasms 3Lung Neoplasms 3Fatigue 3Colorectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Ovarian Neoplasms 2Obesity 2Malnutrition 2Lymphedema 2Insulin Resistance 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Colonic Neoplasms 2Cardiovascular Diseases 2Weight Cycling 1Waldenstrom Macroglobulinemia 1Uveal Melanoma 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Testicular Neoplasms 1

Interventions

Oxaliplatin 13Bevacizumab 11Capecitabine 10Fluorouracil 8Blood Specimen Collection 8Leucovorin 7Cetuximab 7Folfox protocol 6pembrolizumab 5Drug Therapy 5trifluridine tipiracil drug combination 4dostarlimab 4Nivolumab 4Irinotecan 4HMPL-013 4fludarabine 3XELOX 3Specimen Handling 3IFL protocol 3Cyclophosphamide 3Biopsy 3toripalimab 2tislelizumab 2tipiracil 2regorafenib 2pertuzumab 2envafolimab 2encorafenib 2cemiplimab 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Colonic Neoplasms × Exercise × Clear all
NCT05773144 2026-01-07

ACTION

AdventHealth Translational Research Institute

Phase NA Recruiting
219 enrolled
Gastrointestinal

Colonic Neoplasms

NCT05789433 2025-07-03

RESTORE

AdventHealth Translational Research Institute

Phase NA Recruiting
70 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡